No takes yet. Share an insight, caveat, or question.
Randomized trial shows MitoQ reverses endothelial disruption in acute lung injury, suggesting its potential as a treatment.
Cen et al. (2021) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: